IL1B and cardiovascular disorder: Clinical trials have confirmed that IL-1β and its receptor antagonist could be used to treat a variety of cardiovascular diseases [13, 14], and the widely used drug glyburide played a crucial role in the treatment of cardiovascular diseases through the inhibition of the NLRP3 inflammasome [15].